Cardiovascular disease is the leading cause of morbidity and mortality in those living with diabetes. In fact, those with diabetes are 3x more likely to die of heart disease and do so 15 years earlier than individuals without diabetes. Consequently, it is imperative for healthcare providers to engage, learn, and challenge one another on how to best care for patients at risk, or affected by, both diseases.
The Peter Munk Cardiac Centre (PMCC) and the Banting & Best Diabetes Centre (BBDC) have garnered a worldwide reputation as leaders in the fields of cardiovascular disease and diabetes. The Joint Cardiovascular-Diabetes Symposium is a novel partnership that will help transform the landscape of cardiovascular and diabetes care.
After attending this symposium, you will be better able to:
- Summarize the latest evidence on microvascular and macrovascular risk reduction in diabetes and integrate latest recommendations into clinical practice
- Discuss heart failure management in specific circumstances, including patients with diabetes, cardiac complications of cancer therapies, SGLT2 inhibitors in heart failure, and contemporary out-patient management of heart failure using evidence-based therapies
- Understand the impact of viral disease including COVID 19 on those with diabetes and cardiovascular disease
- Identify contemporary management of coronary artery disease, including primary prevention, secondary prevention and advanced intervention
- Family Physicians